Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Stupp

Showing results (91-100 of 314) with videos related to

Pageof 32
Sort By:
The Lancet. Oncology|July 31, 2013
Molecular neuro-oncology in clinical practice: a new horizonMichael Weller, Stefan M Pfister, Wolfgang Wick, et al.
Neuro-Oncology Practice|October 1, 2021
Tumor type, epilepsy burden, and seizure documentation: experiences at a single center neuro-oncology clinicOmar Bushara, Alex Guzner, Elizabeth Bachman, et al.
Cancer Immunology, Immunotherapy : CII|October 7, 2017
Ipilimumab and early signs of pulmonary toxicity in patients with metastastic melanoma: a prospective observational studyDaniel Franzen, Karin Schad, Benedikt Kowalski, et al.
Future Oncology (London, England)|March 23, 2011
Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignanciesDavid A Reardon, Bart Neyns, Michael Weller, et al.
Nature Clinical Practice. Oncology|June 8, 2006
Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomideVincent Ganière, Grégoire Christen, Frank Bally, et al.
Neuro-Oncology|February 18, 2009
Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitroGabriele D Maurer, Isabel Tritschler, Barbara Adams, et al.
Current Opinion in Neurology|October 27, 2011
Medulloblastomas in adults: prognostic factors and lessons from paediatricsCristina Nay Fellay, Didier Frappaz, Marie P Sunyach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patientsSandrine Ostermann, Chantal Csajka, Thierry Buclin, et al.
Oncology (Williston Park, N.Y.)|March 14, 2019
Newly Diagnosed Glioblastoma: A Review on Clinical ManagementRimas V Lukas, Derek A Wainwright, Erik Ladomersky, et al.
Diagnostic Pathology|June 7, 2018
B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphomaRodrigo Javier, Nawal Shaikh, Maciej S Lesniak, et al.
Pageof 32

Showing results (91-100 of 314) with videos related to

Sort By:
Pageof 32
The Lancet. Oncology|July 31, 2013
Molecular neuro-oncology in clinical practice: a new horizonMichael Weller, Stefan M Pfister, Wolfgang Wick, et al.
Neuro-Oncology Practice|October 1, 2021
Tumor type, epilepsy burden, and seizure documentation: experiences at a single center neuro-oncology clinicOmar Bushara, Alex Guzner, Elizabeth Bachman, et al.
Cancer Immunology, Immunotherapy : CII|October 7, 2017
Ipilimumab and early signs of pulmonary toxicity in patients with metastastic melanoma: a prospective observational studyDaniel Franzen, Karin Schad, Benedikt Kowalski, et al.
Future Oncology (London, England)|March 23, 2011
Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignanciesDavid A Reardon, Bart Neyns, Michael Weller, et al.
Nature Clinical Practice. Oncology|June 8, 2006
Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomideVincent Ganière, Grégoire Christen, Frank Bally, et al.
Neuro-Oncology|February 18, 2009
Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitroGabriele D Maurer, Isabel Tritschler, Barbara Adams, et al.
Current Opinion in Neurology|October 27, 2011
Medulloblastomas in adults: prognostic factors and lessons from paediatricsCristina Nay Fellay, Didier Frappaz, Marie P Sunyach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patientsSandrine Ostermann, Chantal Csajka, Thierry Buclin, et al.
Oncology (Williston Park, N.Y.)|March 14, 2019
Newly Diagnosed Glioblastoma: A Review on Clinical ManagementRimas V Lukas, Derek A Wainwright, Erik Ladomersky, et al.
Diagnostic Pathology|June 7, 2018
B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphomaRodrigo Javier, Nawal Shaikh, Maciej S Lesniak, et al.
Pageof 32